dihexa hgf c-met potentiator The HGF/c-Met Axis: A Promising Therapeutic Target in Cancer Targeting cancer-associated fibroblast-activated HGF/c-MET pathway

Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive Antidementia Agents PMC HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted HGF c Met pathway inhibition combined with chemotherapy increases cytotoxic T cell infiltration and inhibits pancreatic tumour growth and metastasis ScienceDirect

SKU: 36717584937 · From southroadsurgery.com.au